End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
81,900 KRW | -0.49% |
|
+3.15% | +125.62% |
2023 | Cosmecca Korea Co., Ltd.(KOSDAQ:A241710) added to S&P Global BMI Index | CI |
2023 | Cosmecca Korea Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+125.62% | 637M | - | ||
-8.44% | 241B | B- | ||
+16.41% | 19.88B | B+ | ||
0.00% | 19.55B | - | - | |
+10.28% | 11.87B | A- | ||
-15.94% | 9.01B | A- | ||
+6.76% | 6.93B | B+ | ||
+8.20% | 5.85B | B | ||
-10.12% | 4.14B | C- | ||
-5.57% | 4.05B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A241710 Stock
- Ratings Cosmecca Korea Co., Ltd.